echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Cardiovasc Diabetol: Comparison of prognostic prediction and stratification of different insulin resistance surrogate indicators for patients with type 2 diabetes after percutaneous coronary intervention

    Cardiovasc Diabetol: Comparison of prognostic prediction and stratification of different insulin resistance surrogate indicators for patients with type 2 diabetes after percutaneous coronary intervention

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    BACKGROUND: Insulin resistance (IR) and the heart is closely related to vascular disease , insulin resistance evaluation difficult and complex
    .


    Recently, various IR alternative indicators have been proposed and proved to be highly correlated with IR evaluated by the gold standard


    Insulin resistance (IR) and heart are closely related to vascular disease heart recently, IR various surrogate markers have been proposed, and proved to be highly related to the gold standard IR evaluation


    Results: 2107 patients (60.
    02±9.
    03 years old, 28.
    0% female) finally entered the study
    .


    During the 24-month follow-up, a total of 187 cases (8.


    Figure 1 The incidence of MACCE is calculated based on the median of the respective IR substitutes in the total population
    .


    MACCE main adverse cardiovascular and cerebrovascular events, TYG triglyceride-glucose, VAI visceral obesity index, CVAI Chinese visceral obesity index, LAP lipid accumulation product, TG/HDL-C triglyceride/high-density lipoprotein cholesterol ratio

    Figure 1 The incidence of MACCE is calculated based on the median of the respective IR substitutes in the total population


    Figure 2 Based on the median of the total population TYG index (A), VAI (B), CVAI (C), LAP (D) and TG/HDL-C (E), the Kaplan-Meier curve of the survival rate without MACCE was calculated
    .


    MACCE main adverse cardiovascular and cerebrovascular events, insulin resistance

    Figure 2 Based on the median of the total population TYG index (A), VAI (B), CVAI (C), LAP (D) and TG/HDL-C (E), the Kaplan-Meier curve of the survival rate without MACCE was calculated


    Table 1 The predictive value of different IR surrogate indicators for MACCE risk in the whole population

    Table 1 The predictive value of different IR surrogate indicators for MACCE risk in the whole population

    Figure 3 The drug susceptibility analysis is carried out by stratification according to the medication situation at the time of admission
    .


    Adjusted smoking history, hypertension, T2 DM, previous MI, previous PCI, previous stroke, clinical diagnosis, TC, hs-CRP, EGFR, HbA1c, LVEF, ACEI/ARB at discharge, oral antidiabetic drugs at discharge, and discharge at discharge Insulin, LM disease, three-vessel disease, chronic complete occlusion, grammatical score, complete revascularization and number of stents


    Figure 3 The drug susceptibility analysis is carried out by stratification according to the medication situation at the time of admission


    Figure 4 Based on the TYG index (A), VAI (B), CVAI (C), LAP (D) and TG/HDL-C (E), three splines are used to limit the risk of MACCE
    .


    Adjusted smoking history, hypertension, T2 DM, previous MI, previous PCI, previous stroke, clinical diagnosis, TC, hs-CRP, EGFR, HbA1c, LVEF, ACEI/ARB at discharge, oral antidiabetic drugs at discharge, and discharge at discharge Insulin, LM disease, three-vessel disease, chronic complete occlusion, grammatical score, complete revascularization and number of stents


    Figure 4 Based on the TYG index (A), VAI (B), CVAI (C), LAP (D) and TG/HDL-C (E), three splines are used to limit the risk of MACCE


    Table 2 Diagnostic performance of MACCE IR surrogate indicators in the whole population

    Table 2 Diagnostic performance of MACCE IR surrogate indicators in the whole population

    Figure 5 ROC curve evaluating the diagnostic performance of each IR surrogate index of MACCE in the total population
    .


    Triglyceride-glucose, VAI visceral obesity index, CVAI Chinese visceral obesity index, LAP lipid accumulation product, TG/HDL-C triglyceride/high-density lipoprotein cholesterol ratio

    Figure 5 ROC curve evaluating the diagnostic performance of each IR surrogate index of MACCE in the total population
    .
    Triglyceride-glucose, VAI visceral obesity index, CVAI Chinese visceral obesity index, LAP lipid accumulation product, TG/HDL-C triglyceride/high-density lipoprotein cholesterol ratio

    Conclusion: The TYG index has the strongest correlation with MACCE risk, and can be used as the most valuable IR surrogate index for predicting and stratifying NSTE-ACS patients (with or without T2 DM) undergoing PCI
    .

    The TYG index has the strongest correlation with MACCE risk, and can be used as the most valuable IR surrogate index for predicting and stratifying NSTE-ACS patients (with or without T2 DM) undergoing PCI
    .

    Original source:

    Zhao Q, Cheng YJ, Xu YK,et al, Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
    Cardiovasc Diabetol 2021 Sep 18;20(1)

    Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.